Zydus Lifesciences added 1.38% to Rs 891.60 after it received final approval from US Food & Drug Administration (USFDA) for manufacturing and marketing of Isosorbide Mononitrate extended-release tablets.
| Subscribe To Our Free Newsletter |
The Most Valuable Commodity Is Information!
